From: Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers
Tumour type 1 | Tumour type 2 | Significantly higher concentration in tumour type 1 | Significantly higher concentration in tumour type 2 |
---|---|---|---|
lymphoma | Astrocytoma II | Â | Â |
lymphoma | Astrocytoma III | Â | Â |
lymphoma | GBM | Tau* | Â |
lymphoma | Metastasis | h-Tau | Â |
lymphoma | Meningioma | Cr* | Ala**, Glu*, Gln**, Lac* |
Astrocytoma II | Astrocytoma III | Â | Â |
Astrocytoma II | GBM | m-Ins* | Ala |
Astrocytoma II | Metastasis | Gln*, m-Ins*, | PE* |
Astrocytoma II | Meningioma | Cr**, GPC**, His**, m-Ins**, s-Ins** | Ala**, Glu*, GSH**, PE |
Astrocytoma III | GBM | Â | Â |
Astrocytoma III | Metastasis | h-Tau* | Â |
Astrocytoma III | Meningioma | GPC*, m-Ins* | GSH*, Lys |
GBM | Metastasis | Cr, Gln*, Gly*, h-Tau* | Â |
GBM | Meningioma | Asp, Cr**, GPC*, His*, m-Ins**, NAA*, s-Ins** | Ala, Glu*, GSH**, Ile*, Tau, Val* |
Metastasis | Meningioma | Cr* | Ala**, Glu*, Gln**, Lac* |